Back
Immatics NV 10K Form
Sell
27
IMTX
Immatics NV
Last Price:
7.66
Seasonality Move:
-1.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMTX News And Ratings
See the #1 stock for the next 7 days that we like better than IMTX
IMTX Financial Statistics
Sales & Book Value
Annual Sales: | $58.46M |
---|---|
Cash Flow: | $-38.36M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.03 |
Price / Book: | 1.94 |
Profitability
EPS (TTM): | -0.89800 |
---|---|
Net Income (TTM): | $-79.72M |
Gross Margin: | -- |
Return on Equity: | -24.96% |
Return on Assets: | -13.99% |
Immatics NV Earnings Forecast
Key Immatics NV Financial Ratios
- The Research & Development expenses have been 219.76% of Revenue.
- The Interest Expense is -0.86% of Operating Income.
- The Net Earning history of IMTX is -179.63% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Immatics NV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | IMTX |
Website: | immatics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.74 |
Quick Ratio: | 3.58 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
IMTX Technical Analysis vs Fundamental Analysis
Sell
27
Immatics NV (IMTX)
is a Sell
Is Immatics NV a Buy or a Sell?
-
Immatics NV stock is rated a Sell
The current Immatics NV [IMTX] share price is $7.80. The Score for IMTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.